16830 Results from the open-label treatment period of a long-term proactive management phase III trial using fixed-dose combination calcipotriene 0.005% and betamethasone dipropionate 0.064% foam
| Autor: | Lebwohl, Mark, Philippe LACOUR, Jean, Liljedahl, Monika, Lynde, Charles, Mørch, Marie, Snel-Prentø, Anja, Pharma, L.E.O., Thaci, Diamant, Warren, Richard B. |
|---|---|
| Zdroj: | In Journal of the American Academy of Dermatology December 2020 83(6) Supplement:AB187-AB187 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect